Company Details and Contacts | Nyne.ai

BerGenBio: Developing first-in-class AXL inhibitors for aggressive diseases, including advanced, treatment resistant cancers

Yvonne McGovern

Associate Director, Programme Management

Viki Wills

Head of Development Operations

Richard Godfrey

Senior Executive Consultant and Board Member

Shinofa Rizan

QA and Business Operations

Gro Gausdal

Gausdal BioConsulting AS

Stuart Mcpherson

Associate Director Clinical Operations